Clinical Trial

REDCURE Registry for Chronic Kidney Disease (CKD) Anemia

Study acronym: REDCURE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A local registry on CKD-associated anemia aims to provide real-world insights into disease burden, treatment patterns, and outcomes at the national level. It helps capture variations in anemia severity with CKD stages, therapeutic practices and their response. It also supports evidence-based decision-making, identifies gaps in care, and informs locally relevant guidelines and policy planning to improve patient outcomes with oral novel therapy i.e. daprodustat
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-08.
Trial Details
NCT Number NCT07346547
Lead Sponsor Nabiqasim Industries (Pvt) Ltd
Conditions CKD Anemia
Enrollment 384 participants
Start Date 2026-01-30
Primary Completion 2027-01-30 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-20